11C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparison

NeuroImage

Volumn 49, Issue 4, 2010, Pages 2977-2982

  Okita, Yoshiko ^a   Kinoshita, Manabu ^a   Goto, Tetsu ^a   Kagawa, Naoki ^a   Kishima, Haruhiko ^a   Shimosegawa, Eku ^a   Hatazawa, Jun ^a   Hashimoto, Naoya ^a   Yoshimine, Toshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

11C methionine positron emission tomography (11C methionine PET); Angiogenesis; Glioma; Microvessel density; Proliferation; Tumor cell density

Indexed keywords

CARBON 11; KI 67 ANTIGEN; METHIONINE;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; CANCER CELL; CELL DENSITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MICROVASCULATURE; MULTIPLE LINEAR REGRESSION ANALYSIS; PATIENT ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; STEREOTACTIC BIOPSY; TUMOR VASCULARIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CELL COUNT; CHILD; FEMALE; GLIOMA; HUMANS; IMAGING, THREE-DIMENSIONAL; METHIONINE; MICROVESSELS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STATISTICS AS TOPIC; STEREOTAXIC TECHNIQUES; YOUNG ADULT;

EID: 73749085596     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.11.024     Document Type: Article

References (32)

1. 11C-labelled radiopharmaceuticals: imipramine, chlorpromazine, nicotine and methionine. Int. J. Appl. Radiat. Isot. 30 (1979) 393-399
2. Bergstrom M., Ericson K., Hagenfeldt L., Mosskin M., von Holst H., Noren G., Eriksson L., Ehrin E., and Johnstrom P. PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids. J. Comput. Assist. Tomogr. 11 (1987) 208-213
3. 11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol. 28 (1987) 225-229
4. Braun V., Dempf S., Weller R., Reske S.N., Schachenmayr W., and Richter H.P. Cranial neuronavigation with direct integration of (11)C methionine positron emission tomography (PET) data-results of a pilot study in 32 surgical cases. Acta Neurochir. (Wien) 144 (2002) 777-782 discussion 782
5. Bustany P., Chatel M., Derlon J.M., Darcel F., Sgouropoulos P., Soussaline F., and Syrota A. Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with C11-l-methionine. J. Neurooncol. 3 (1986) 397-404
6. Christensen H.N. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 70 (1990) 43-77
7. 18F-FDG PET. Eur. J. Nucl. Med. Mol. Imaging 29 (2002) 176-182
8. Derlon J.M., Bourdet C., Bustany P., Chatel M., Theron J., Darcel F., and Syrota A. [11C]l-methionine uptake in gliomas. Neurosurgery 25 (1989) 720-728
9. 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. Eur. J. Nucl. Med. Mol. Imaging 33 (2006) 516-524
10. Hatazawa J., Ishiwata K., Itoh M., Kameyama M., Kubota K., Ido T., Matsuzawa T., Yoshimoto T., Watanuki S., and Seo S. Quantitative evaluation of l-[methyl-C-11] methionine uptake in tumor using positron emission tomography. J. Nucl. Med. 30 (1989) 1809-1813
11. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50 (1998) 1316-1322
12. Jacobs A.H., Dittmar C., Winkeler A., Garlip G., and Heiss W.D. Molecular imaging of gliomas. Mol. Imaging 1 (2002) 309-335
13. 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J. Nucl. Med. 46 (2005) 1948-1958
14. Jacobs A.H., Winkler A., Dittmar C., Gossman A., Deckert M., Kracht L., Thiel A., Garlip G., Hilker R., Sobesky J., Vollmar S., Kummer C., Graf R., Voges J., Wienhard K., Herholz K., and Heiss W.D. Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas. Technol. Cancer Res. Treat. 1 (2002) 187-204
15. 11C-choline positron-emission tomography. AJNR Am. J. Neuroradiol. 29 (2008) 1176-1182
16. Kinoshita M., Hashimoto N., Goto T., Kagawa N., Kishima H., Izumoto S., Tanaka H., Fujita N., and Yoshimine T. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage 43 (2008) 29-35
17. Knudsen G.M., Pettigrew K.D., Patlak C.S., Hertz M.M., and Paulson O.B. Asymmetrical transport of amino acids across the blood-brain barrier in humans. J. Cereb. Blood Flow Metab. 10 (1990) 698-706
18. 11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur. J. Nucl. Med. Mol. Imaging 30 (2003) 868-873
19. 11C]l-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin. Cancer Res. 10 (2004) 7163-7170
20. Levivier M., Massager N., Wikler D., Lorenzoni J., Ruiz S., Devriendt D., David P., Desmedt F., Simon S., Van Houtte P., Brotchi J., and Goldman S. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. J. Nucl. Med. 45 (2004) 1146-1154
21. Mineura K., Sasajima T., Kowada M., Uesaka Y., and Shishido F. Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-l-methionine positron emission tomography. J. Nucl. Med. 32 (1991) 726-728
22. Miwa K., Shinoda J., Yano H., Okumura A., Iwama T., Nakashima T., and Sakai N. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1457-1462
23. 11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J. Neurosurg. 103 (2005) 498-507
24. Nojiri T., Nariai T., Aoyagi M., Senda M., Ishii K., Ishiwata K., and Ohno K. Contributions of biological tumor parameters to the incorporation rate of l-[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas. J. Neurooncol. 93 (2009) 233-241
25. Ogawa T., Shishido F., Kanno I., Inugami A., Fujita H., Murakami M., Shimosegawa E., Ito H., Hatazawa J., Okudera T., et al. Cerebral glioma: evaluation with methionine PET. Radiology 186 (1993) 45-53
26. Sadeghi N., Salmon I., Decaestecker C., Levivier M., Metens T., Wikler D., Denolin V., Rorive S., Massager N., Baleriaux D., and Goldman S. Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. AJNR Am. J. Neuroradiol. 28 (2007) 455-461
27. Souba W.W., and Pacitti A.J. How amino acids get into cells: mechanisms, models, menus, and mediators. JPEN J. Parenter. Enteral. Nutr. 16 (1992) 569-578
28. Stadlbauer A., Ganslandt O., Buslei R., Hammen T., Gruber S., Moser E., Buchfelder M., Salomonowitz E., and Nimsky C. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 240 (2006) 803-810
29. Stockhammer F., Plotkin M., Amthauer H., van Landeghem F.K., and Woiciechowsky C. Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas. J. Neurooncol. 88 (2008) 205-210
30. Torii K., Tsuyuguchi N., Kawabe J., Sunada I., Hara M., and Shiomi S. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Ann. Nucl. Med. 19 (2005) 677-683
31. Veninga T., Huisman H., van der Maazen R.W., and Huizenga H. Clinical validation of the normalized mutual information method for registration of CT and MR images in radiotherapy of brain tumors. J. Appl. Clin. Med. Phys. 5 (2004) 66-79
32. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur. J. Nucl. Med. 27 (2000) 542-549